Q1 EPS Estimate for Daré Bioscience Reduced by Analyst
Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Brookline Capital Management cut their Q1 2025 earnings per share estimates for shares of Daré Bioscience in a report issued on Monday, March 31st. Brookline Capital Management analyst K. Dolliver now anticipates that the biotechnology company will post earnings per share of ($0.68) for the quarter, down […]
Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Brookline Capital Management cut their Q1 2025 earnings per share estimates for shares of Daré Bioscience in a report issued on Monday, March 31st. Brookline Capital Management analyst K. Dolliver now anticipates that the biotechnology company will post earnings per share of ($0.68) for the quarter, down […]
